Please assess the completion status of the following clinical trial:

Trial Title: The Role Of Empiric Dilation In Patients With Dysphagia With Normal Endoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients age: \> 18 years.~2. Outpatients undergoing EGD for dysphagia.~3. Ability to provide written informed consent.~Exclusion Criteria:~* Abnormal endoscopy (stricture, abnormal motility or mucosa observed)~* Oropharyngeal dysphagia suspected based on history and physical examination~* History of CVA or other neurologic disorder~* Known connective tissue disease (SLE, scleroderma, CREST, RA)~* Known histopathology based esophageal motor disorder, e.g. achalasia~* Prior thoracic or foregut surgery (excluding cholecystectomy)~* Prior thoracic radiation therapy~* Hiatus hernia \>2 cm as judged during EGD

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- dilation to 27 French (Type: PLACEBO_COMPARATOR): None
- Dilation of the esophagus to 54 French (Type: EXPERIMENTAL): Esophagus will be dilated with a Savory dilator

Based on this trial design, predict the completion outcome and termination type (if applicable).